EE57 Real-World Reductions in Migraine-Related Health Care Resource Utilization and Costs for Patients Initiating Fremanezumab: A 12-Month Retrospective US Claims Analysis
Abstract
Authors
MT Driessen LJ Krasenbaum V Ramirez-Campos R DiEgidio M Tian MJ Seminerio